Seneste opdatering :
19/11/2024
Antisvampe   Amphotericin B lipid complex  
Injektion
Stabilitet i (vandige) opløsninger Stabilitet i blandinger Faktorer der påvirker stabiliteten Kompatibilitet Administrationsvej Bibliografi pdf
   Kemisk struktur  

Handelsnavn   Handelsnavn     

Handel navne er vejledende og hjælpestoffer sammensætning kan være forskellig afhængigt af landet og laboratorier

Abelcet Argentina, Australien, Belgien, Brasilien, Canada, Danmark, Finland, Frankrig, Grækenland, Holland, Irland, Italien, Luxemborg, Malaysia, Marokko, Mexico, Norge, Portugal, Rumænien, Spanien, Storbritanien, Sverige, Tyskland, Ungarn, USA, Østrig
Bibliografi   Injektion   Bibliografi : Amphotericin B lipid complex  
Type offentliggørelse
1510 Bog AHFS Formulary service 2000 Bethesda - 3546 p
2247 Journal Chan P, Heatherly K, Kupiec T.C, Trissel L.A.
Compatibility of caspofungin acetate injection with other drugs during simulated Y-site coadministration.
Int J Pharm Compound 2008 ; 12, 3: 276-278.
2262 Journal Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D.
Compatibility of doripenem with other drugs during simulated Y-site administratioN
Am J Health-Syst Pharm 2008 ; 65: 1261-1265.
3254 Journal Housman S.T, Tessier P.R, Nicolau D.P, Kuti J.L.
Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration
Am J Health-Syst Pharm 2011 ; 68: 2265-2270.
3332 Laboratorium Tigecycline (Tigacyl®) - Summary of Product characteristics
Pfizer 2012
3644 Laboratorium Calcium gluconate® - Summary of Product Characteristics
Hameln Pharmaceuticals 2010
3828 Poster Thabit A.K, Hamada Y, Nicolau D.P.
Ceftozolane/tazobactam physical compatibility during simulated Y-site administration.
ASHP Midyear 2015
3829 Poster So W, Kim L, Thabit A.K, Nicolau D.P, Kuti J.L.
Compatibility of isavunazonium sulfate during simulated Y-site administration.
ASHP Midyear 2015
4055 Journal Monogue M, Almarzoky Abuhussain S, Kuti J, Nicolau D.
Physical compatibility of fosfomycin for injection with select i.v. drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2018 , 75, 1:36-44

  Mentions Légales